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Abstract
Objective: This study aimed to evaluate if the Gyrus open forceps is a safe and efficient tool for hepatic
parenchymal transection.
Background: Blood loss during hepatic transection remains a significant risk factor for morbidity and
mortality associated with liver surgery. Various electrosurgical devices have been engineered to reduce
blood loss. The Gyrus open forceps is a bipolar cautery device which has recently been introduced into
hepatic surgery.
Methods: We conducted a single-institution, retrospective review of all liver resections performed from
November 2005 through November 2007. Patients undergoing resection of at least two liver segments
where the Gyrus was the primary method of transection were included. Patient charts were reviewed;
clinicopathological data were collected.
Results: Of the 215 open liver resections performed during the study period, 47 patients met the
inclusion criteria. Mean patient age was 61 years; 34% were female. The majority required resection for
malignant disease (94%); frequent indications included colorectal metastasis (66%), hepatocellular car-
cinoma (6%) and cholangiocarcinoma (4%). Right hemihepatectomy (49%), left hemihepatectomy (13%)
and right trisectionectomy (13%) were the most frequently performed procedures. A total of 26 patients
(55%) underwent a major ancillary procedure concurrently. There were no operative mortalities. Median
operative time was 220 min (range 97–398 min). Inflow occlusion was required in nine patients (19%) for
a median time of 12 min (range 3–30 min). Median total estimated blood loss was 400 ml (range
10–2000 ml) and 10 patients (21%) required perioperative transfusion. All patients had macroscopically
negative margins. Median length of stay was 8 days. Two patients (4%) had clinically significant bile leak.
The 30-day postoperative mortality was zero.
Conclusions: Use of the Gyrus open forceps appears to be a safe and efficient manner of hepatic
parenchymal transection which allows rapid transection with acceptable blood loss, a low rate of
perioperative transfusion, and minimal postoperative bile leak.
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Introduction
The morbidity and mortality of hepatic resection have declined
dramatically over the last three decades.1,2 This improvement has
largely reflected a reduction in the amount of blood loss encoun-
tered during resection and can be attributed to improved under-
standing of hepatic anatomy, refinement of surgical technique and
advances in surgical technology. Despite these improvements, the
transection of hepatic parenchyma remains the major source of
blood loss and continues to be a relative barrier to hepatic surgery.
The finger fracture method was first described in 19743 as
the original method for controlling haemorrhage from the
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transection plane during hepatic parenchymal resection. The
introduction of various new surgical devices has attempted to
refine this method.4–16 For example, ultrasonic dissection has been
used to atraumatically divide the hepatic parenchyma and expose
the hepatic vasculature and bile ducts. The use of electrosurgical
devices has allowed for the precoagulation of hepatic parenchyma
and the simultaneous sealing of vessels and bile ducts during
transection.With these refinements, routine hepatic resection has
become relatively safe and major blood loss is infrequently
encountered; however, no clearly superior method of hepatic
parenchymal transection has been identified.
Despite the development of numerous technologically
advanced instruments for the division of hepatic parenchyma, the
use of the finger fracture method still predominates during open
procedures. In a recent survey of practising high-volume liver
surgeons, over 10 different devices were reported to be frequently
used for parenchymal transection. The finger fracture method and
the Cavitron ultrasonic surgical aspirator (CUSA) were the most
often utilized methods of transection in major hepatic resection,
by 58% and 43% of responding surgeons, respectively.17 The least
frequently used devices included the Enseal device and the Gyrus
open forceps. The survey illustrated that a variety of methods are
currently employed by active hepatic surgeons and demonstrated
that choice of transection method frequently depends on surgeon
preference.
Although the Gyrus open forceps was shown to be an infre-
quently used device in the survey, our initial experience demon-
strated that its use facilitated rapid transection and excellent
haemostasis, which prompted this retrospective study. The Gyrus
open forceps (Gyrus ACMI, Inc., Southborough, MA, USA) is a
bipolar cautery device which has been used extensively in open
gynaecological surgery for a variety of surgical procedures, but has
only recently been applied to hepatic surgery. When used for
parenchymal transection, the Gyrus open forceps seals the hepatic
parenchyma using a combination of pressure and energy that
results in the fusion of collagen and elastin in the walls of the
hepatic vasculature and bile ducts. The device can reliably seal
vessels up to 7 mm in diameter, minimizing the amount of blood
loss during transection. This report describes our initial experi-
ence using the Gyrus open forceps for hepatic parenchymal
transection.
Materials and methods
Study design and patient selection
After obtaining approval from the institutional review board,
a single-centre retrospective review was performed to identify
patients who underwent liver resection during a 2-year period
beginning in November 2005. Patients who underwent hepatic
resections which utilized the Gyrus open forceps as the primary
mode of transection and whose tumours required resection of at
least two Couinaud liver segments were included.Data for analysis
included demographics, clinical history, operative findings, patho-
logical results, 30-day mortality and postoperative complications.
Primary endpoints included total intraoperative blood loss, the
use of inflow occlusion and receipt of transfusion. The terminol-
ogy used in this paper is based on the Brisbane 2000 terminology
of the International Hepato-Pancreato-Biliary Association.18
Surgical procedure
All liver resections were performed in the standard manner by
dedicated liver surgeons from the Section of Hepato-Pancreato-
Biliary Surgery, Department of Surgery, Washington University.
Each patient underwent an intraoperative ultrasound examina-
tion to define the location of the tumour in relation to the major
vasculature and biliary structures. All resections were performed
with a low central venous pressure (0–5 mmHg).When indicated,
vascular or pedicle ligation was performed in the routine manner
prior to hepatic transection. Inflow occlusion was not routinely
performed and only considered when the degree of blood loss was
likely to result in blood transfusion.
The Gyrus open forceps (Fig. 1) is a bipolar cautery device used
in a similar manner to the clamp–crush technique to transect
hepatic parenchyma. After incising the hepatic capsule with Bovie
electrocautery, the forceps are inserted into the liver in an open
manner. Using a foot pedal, bipolar energy is applied as the
forceps are slowly closed over the parenchyma. An audible signal
indicates the completion of the cycle. A second application of
energy is often used. The cauterized liver is subsequently
transected with Metzenbaum scissors. The device was used for the
entire hepatic parenchymal transection; only named vascular and
biliary structures required additional attention and were stapled
or suture ligated.
On completion of the parenchymal transection, the cut surface
of the liver was inspected for haemostasis and bile leakage.
3.0 cm 
Figure 1 Gyrus open forceps
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Routine closed suction drainage was performed in patients who
underwent biliary reconstruction, or at the surgeon’s discretion.
Results
The Gyrus device was used as the primary method of liver paren-
chymal transection in 58 patients undergoing liver resection at
Washington University between November 2005 and November
2007. Eleven patients who underwent resection of less than two
hepatic segments were excluded. The final cohort comprised 47
patients including 16 women and 31 men (median age 61 years,
range 27–84 years). The most common indication for surgery was
metastatic colorectal cancer confined to the liver. Less common
diagnoses included hepatocellular carcinoma, cholangiocarci-
noma, gallbladder cancer, metastatic breast cancer and benign
disease. Patient and tumour characteristics are listed in Table 1.
The most common procedures performed were right hepatec-
tomy (Couinaud segments 5–8, 23 patients) and left hepatectomy
(Couinaud segments 1–4, six patients). Smaller numbers of
patients underwent trisectionectomy (seven patients), bisegmen-
tectomy (four patients) or mesohepatectomy (two patients)
(Table 2).
In addition to hepatic resection, 26 patients required a concur-
rent ancillary procedure. Eight patients had a liver metastasis
excised during the resection of their primary colorectal tumour.
Bilateral metastases were present in nine patients and required
non-anatomic wedge resection (six patients) or radiofrequency
ablation (three patients). One patient required vascular resection
and reconstruction (Table 3).
Median operative time, inclusive of hepatic resection and all
ancillary procedures, was 220 min. The median resection area was
150 cm2 (range 40–552 cm2) and was transected in a median time
of 25 min (range 15–48 min). Transection time was recorded in a
subset of only 15 patients. The average calculated transection
speed was 4.8 cm2/min in this subset (Table 4).
Inflow occlusion was required in nine (19%) of 47 procedures
for a median time of 12 min (range 3–30 min). Intraoperative
blood loss varied from 10 ml to 2000 ml, with a median blood loss
of 400 ml. Blood loss exceeding 1 litre occurred in three of 47
patients (Table 5). In each of these patients the majority of the
blood loss occurred during associated procedures rather than
during the hepatic parenchymal transection, which included
en-bloc resection of a large leiomyosarcoma, placement of a
hepatic artery infusion pump complicated by a tear in the inferior
vena cava, and en-bloc resection of a large left upper quadrant
sarcoma. Ten patients (21%) received blood transfusions in the
perioperative period, including three patients intraoperatively.
The median number of transfused units was zero. One patient
required re-exploration for intra-abdominal haemorrhage. At the
time of the second surgery, the source of haemorrhage was traced
to a bleeding mesenteric vessel near the resection bed of the col-
orectal primary tumour, and was not related to the use of the
Gyrus device.
Table 1 Indications for hepatectomy in 47 patients
Liver lesion n (%)
Benign 3 (6)
Benign biliary stricture 1 (2)
Secondary sclerosing cholangitis 1 (2)
Adenoma 1 (2)
Malignant 44 (94)
Colon cancer metastasis 25 (53)
Rectal cancer metastasis 6 (13)
Hepatocellular carcinoma 3 (6)
Breast cancer metastasis 2 (4)
Cholangiocarcinoma 2 (4)
Sarcoma 2 (4)
Adrenal cortical carcinoma 1 (2)
Gall bladder cancer 1 (2)
Gastric cancer metastasis 1 (2)
Pancreatic acinar metastasis 1 (2)
Table 2 Type of hepatic resection performed (n = 47)
Type of resection n (%)
Right hemihepatectomy 23 (49)
Left hemihepatectomy 6 (13)
Right trisectionectomy 6 (13)
Left lateral sectionectomy 6 (13)
Right posterior sectionectomy 3 (6)
Mesohepatectomy 2 (4)
Left trisectionectomy 1 (2)
Table 3 Ancillary procedures performed at the time of hepatic
resection
Ancillary procedure n (%)
Synchronous bowel resection 8 (17)
Non-anatomic wedge resection 6 (13)
Portal lymph node dissection 4 (9)
En-bloc tumour resection 4 (9)
One or more hepatic lesions treated with radiofrequency
ablation (RFA)
3 (6)
Vascular reconstruction 1 (2)
Table 4 Median operative values in nine patients (19% of series)
Parameter Median value (range)
Procedure time, min 220 (97–398)
Transection time, min 25 (15–48)a
Transection area, cm2 150 (40–552)
Pringle time, min 12 (3–30)
aData available in 15 patients
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There were no postoperative mortalities within 30 days of the
hepatic resection. Postoperative morbidity was observed in 14
patients (30%) and included: wound infection (one patient); deep
venous thrombosis/pulmonary embolus (five patients); infectious
colitis (four patients); intra-abdominal abscess (one patient);
arrhythmia (one patient); non-ST elevation myocardial infarction
(NSTEMI) (two patients), and respiratory insufficiency requiring
re-intubation (one patient). One patient, who underwent a left
lateral sectionectomy in conjunction with an en-bloc resection of
a pancreatic mass, partial gastectomy, partial colectomy, splenec-
tomy and small bowel resection, developed a pancreatic leak
which resulted in septic shock with multisystem organ dysfunc-
tion, prolonged intubation, infectious colitis, NSTEMI, ileus and
prolonged hospital course. No patients experienced hepatic
failure. Two patients demonstrated clinical bile leak. One patient
required endoscopic placement of a biliary stent across the leaking
bilioenteric anastomosis. The sub-hepatic fluid collection in the
second patient was presumed to have occurred secondary to
ineffective bile duct closure by the device and was resolved with
percutaneous drainage.
Discussion
Hepatic resection remains a challenging and demanding proce-
dure where successful outcomes are closely linked to the ability to
efficiently transect hepatic parenchyma. Successful hepatic paren-
chymal transection requires the simultaneous division of paren-
chyma and sealing of vessels and bile ducts. Numerous devices
have been developed to achieve this goal; however, no single
device has demonstrated clear superiority. In this paper, we ret-
rospectively reviewed one such new device, the Gyrus open
forceps, to evaluate its usefulness for hepatic parenchymal
transection.
Intraoperative blood loss, and the resulting need for periopera-
tive transfusion, can be viewed as one of the greatest negative risk
factors for increased complication rates, worse postoperative
outcome, and shorter disease-free survival.19–21 In our series of 47
consecutive major liver resections, the Gyrus open forceps was
demonstrated to facilitate a safe, effective and efficient method for
hepatic parenchymal transection. The device uses bipolar energy
to permanently seal hepatic veins and arteries along the transec-
tion plane and was routinely used for the entire hepatic parenchy-
mal transection. The device exhibits a minimal thermal spread of
2–3 mm and was frequently used for parenchymal transection
abutting the hepatic hilum. With the exception of large, named
vascular and biliary structures which were routinely stapled or
ligated, excellent haemostasis and biliary duct fusion were
achieved uniformly. In this series, median blood loss rates com-
pared favourably with those in several large series using the tra-
ditional clamp–crush technique.1,2,22,23 In addition, blood loss and
transfusion rates were comparable with those cited in recent
reports of alternative methods of parenchymal transection,5,9,12,16,24
including our prior prospective evaluation of the LigaSure device
(Table 6).
Increased intraoperative blood loss is often associated with the
increased usage of inflow occlusion. Although routine inflow
occlusion is common practice during hepatic transection, there
are instances where inflow occlusion may be undesirable, as in
cases where the ischaemic insult may compromise the liver
remnant. In these cases, where the remaining liver mass is small or
compromised by preoperative jaundice, chemotherapy or under-
lying liver disease, the risk of hepatic failure is increased and
precautions should be taken to avoid unnecessary ischaemic
insult. This study demonstrates that the Gyrus open forceps can be
used in a variety of major anatomic resections without the routine
use of inflow occlusion.
Bile leak after hepatic resection remains a challenging compli-
cation that occurs in about 10% of patients who undergo
surgery.6,25–27 The Gyrus device was consistently able to seal bile
ducts as well as vessels during transection. The rate of symptom-
atic bile leak requiring intervention in the current series was two
in 47 patients (4.2%) and was comparable with rates reported in
recent series.6,16,26–28 Unlike many series, which exclude patients
who require a bilioenteric reconstruction, this series includes all
patients who underwent hepatic resection using the Gyrus open
forceps. These included one patient who developed a bile leak
after resection of a hilar cholangiocarcinoma and biliary recon-
struction. A failed bilioenteric anastomosis was diagnosed by
endoscopy and resolved with biliary stent placement. A second
patient was diagnosed with a bile leak by computed tomography
scan obtained for leucocytosis; the collection was presumed to
have occurred secondary to a failure of the Gyrus device to com-
pletely seal a bile duct. The biloma resolved after radiographically
guided percutaneous drainage. The rate of biliary leak attributable
to the Gyrus device was 1.2% (1/47), which is slightly below rates
in comparable series.
The current review suggests that the Gyrus open forceps is a
rapid and efficient instrument for hepatic parenchymal transec-
tion. In the subset of patients in whom transection time was
recorded, the observed rate (4.8 cm2/min) compared favourably
with the results reported by Lesurtel et al.24 In their prospective
trial, the clamp–crush technique was demonstrated to be the
most rapid method (3.9 cm2/min) compared with the Ultrasonic
Table 5 Blood loss and transfusion data
Parameter Value
Median estimated blood loss, ml (range) 400 (10–2000)
Transfusion rate 21%
Maximum transfusion volume 3u PRBC
Median length of stay, days (range) 8 (2–18)
Clinically significant bile leak 2 (4%)
Grossly negative margins 100%
Microscopic negative margins 98%
Postoperative haemorrhage requiring reoperation 1 (2%)
PRBC, packed red blood cells
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Dissector (2.3 cm2/min), HydroJet (2.4 cm2/min), and TissueLink
(2.5 cm2/min). Currently, the Gyrus appears to be one of the
faster methods of transection. Reduced transection time offers
the benefit of shorter operative times, which may lead to less
morbidity and mortality related to general anaesthetic risk,
operative hypothermia, and haemorrhage from the raw transec-
tion surface.
Despite the favourable findings in regard to transection time,
blood loss and receipt of transfusion, perioperative morbidity in
this series was 30%. However, 60% of patients who experienced
multiple complications, complications requiring procedural inter-
vention or complications resulting in organ dysfunction under-
went additional procedures at the time of hepatic resection. Over
half (55%) the patients underwent combined colorectal resection,
en-bloc sarcoma excision or non-anatomic wedge resection of
additional metastasis, which may have contributed to the relative
increase in observed morbidity. The increase in morbidity may be
a surrogate artefact reflecting procedural complexity.
This series has significant limitations. Most notably, this review
is retrospective, which limits our ability to generalize and compare
results. Additional prospective studies are required to determine
whether the Gyrus open forceps is superior to other instruments
currently used in hepatic parenchymal transection.
Conclusions
The Gyrus open forceps is a safe and efficient tool for hepatic
parenchymal transection. Although the results of this series
compare favourably with those of other reports, further prospec-
tive studies are needed to directly compare outcomes using this
device with those of other methods of open hepatic parenchymal
transection.
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